Hemogenyx Pharmaceuticals Plc (HOPHF)
OTCMKTS · Delayed Price · Currency is USD
2.330
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of $78.8 million as of February 12, 2026. Its market cap has increased by 382.51% in one year.
Market Cap
78.80M
Enterprise Value
81.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.33
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 13.93M to 78.80M, an increase of 465.61%. That is a compound annual growth rate of 23.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 80.76M | 73.64% |
| Dec 31, 2025 | 46.51M | 161.74% |
| Dec 31, 2024 | 17.77M | -48.41% |
| Dec 29, 2023 | 34.44M | 120.18% |
| Dec 30, 2022 | 15.64M | -37.12% |
| Dec 31, 2021 | 24.87M | -56.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 211.61M |
| HST Global | 139.70M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Arch Biopartners | 43.92M |